Avanos Medical (AVNS) Revenue (2013 - 2026)

Avanos Medical has disclosed Revenue across 14 years of filings, most recently posting $182.2 million for Q1 2026.

• Revenue for Q1 2026 came in at $182.2 million, up 8.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $715.9 million (up 3.87% YoY), and the FY2025 annual result was $701.2 million, up 1.95% from the prior year.
• Revenue came in at $182.2 million for Q1 2026 at Avanos Medical, up from $180.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $197.4 million in Q1 2022 to a low of $159.3 million in Q1 2023.
• The 5-year median for Revenue is $172.3 million (2022), against an average of $174.5 million.
• Across the five-year window, Revenue surged 407.26% in 2022 and slipped 19.3% in 2023, its largest moves.
• Avanos Medical's Revenue stood at $181.6 million in 2022, then decreased by 4.57% to $173.3 million in 2023, then gained by 3.64% to $179.6 million in 2024, then advanced by 0.72% to $180.9 million in 2025, then climbed by 0.72% to $182.2 million in 2026.
• The last three Revenue figures came in at $182.2 million (Q1 2026), $180.9 million (Q4 2025), and $177.8 million (Q3 2025), per Business Quant data.